Impairment of hepatic NK cell development in IFN-γ deficient mice

Cytokine

Volumn 60, Issue 3, 2012, Pages 616-625

  Wu, Xian ^a   Chen, Yongyan ^a   Sun, Rui ^a   Wei, Haiming ^a   Tian, Zhigang ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Development; IFN ; Liver; NK cells

Indexed keywords

CD11B ANTIGEN; CD27 ANTIGEN; CD3 ANTIGEN; CD69 ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 2 RECEPTOR BETA; POLYINOSINIC POLYCYTIDYLIC ACID; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BIOACCUMULATION; BONE MARROW CELL; CELL COUNT; CELL MATURATION; CONTROLLED STUDY; GENE; HEPATIC NATURAL KILLER CELL; IFN GAMMA GENE; IMMUNOPATHOLOGY; IN VIVO STUDY; LYMPH NODE CELL; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SPLEEN CELL; STEM CELL;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BONE MARROW CELLS; CELL DIFFERENTIATION; CYTOTOXICITY, IMMUNOLOGIC; GRANZYMES; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIVER; LYMPH NODES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLY I-C; SPLEEN; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

MUS;

EID: 84867991737     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.07.012     Document Type: Article

References (38)

1. Yokoyama W.M., Plougastel B.F. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 2003, 3:304-316.
2. Raulet D.H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 2004, 5:996-1002.
3. Lanier L.L. NK cell recognition. Annu Rev Immunol 2005, 23:225-274.
4. Di Santo J.P. Natural killer cell developmental pathways: a question of balance. Annu Rev Immunol 2006, 24:257-286.
5. Di Santo J.P. Natural killer cells: diversity in search of a niche. Nat Immunol 2008, 9:473-475.
6. Takeda K., Cretney E., Hayakawa Y., Ota T., Akiba H., Ogasawara K., et al. TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. Blood 2005, 105:2082-2089.
7. Wheelock E.F. Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science 1965, 149:310-311.
8. Adolf G.R. Structure and effects of interferon-gamma. Oncology 1985, 42(Suppl. 1):33-40.
9. Bearden I.G., Beavis D., Besliu C., Budick B., Boggild H., Chasman C., et al. Charged meson rapidity distributions in central Au+Au collisions at square root (sNN)=200GeV. Phys Rev Lett 2005, 94:162301.
10. Chu C.Q., Wittmer S., Dalton D.K. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J Exp Med 2000, 192:123-128.
11. Ferber I.A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., et al. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 1996, 156:5-7.
12. Maldonado R.A., Soriano M.A., Perdomo L.C., Sigrist K., Irvine D.J., Decker T., et al. Control of T helper cell differentiation through cytokine receptor inclusion in the immunological synapse. J Exp Med 2009, 206:877-892.
13. Bradley L.M., Dalton D.K., Croft M. A direct role for IFN-gamma in regulation of Th1 cell development. J Immunol 1996, 157:1350-1358.
14. Lund R.J., Loytomaki M., Naumanen T., Dixon C., Chen Z., Ahlfors H., et al. Genome-wide identification of novel genes involved in early Th1 and Th2 cell differentiation. J Immunol 2007, 178:3648-3660.
15. Young H.A., Klinman D.M., Reynolds D.A., Grzegorzewski K.J., Nii A., Ward J.M., et al. Bone marrow and thymus expression of interferon-gamma results in severe B-cell lineage reduction, T-cell lineage alterations, and hematopoietic progenitor deficiencies. Blood 1997, 89:583-595.
16. Takeda K., Smyth M.J., Cretney E., Hayakawa Y., Yamaguchi N., Yagita H., et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth. Cell Immunol 2001, 214:194-200.
17. Smyth M.J., Cretney E., Takeda K., Wiltrout R.H., Sedger L.M., Kayagaki N., et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med 2001, 193:661-670.
18. Dalton D.K., Pitts-Meek S., Keshav S., Figari I.S., Bradley A., Stewart T.A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993, 259:1739-1742.
19. Hoshino T., Winkler-Pickett R.T., Mason A.T., Ortaldo J.R., Young H.A. IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. J Immunol 1999, 162:51-59.
20. Sun R., Tian Z., Kulkarni S., Gao B. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners. J Immunol 2004, 172:5648-5655.
21. Lambe T., Crawford G., Johnson A.L., Crockford T.L., Bouriez-Jones T., Smyth A.M., et al. DOCK8 is essential for T-cell survival and the maintenance of CD8+ T-cell memory. Eur J Immunol 2011, 41:3423-3435.
22. Vosshenrich C.A., Ranson T., Samson S.I., Corcuff E., Colucci F., Rosmaraki E.E., et al. Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol 2005, 174:1213-1221.
23. Yu H., Fehniger T.A., Fuchshuber P., Thiel K.S., Vivier E., Carson W.E., et al. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. Blood 1998, 92:3647-3657.
24. Williams N.S., Moore T.A., Schatzle J.D., Puzanov I.J., Sivakumar P.V., Zlotnik A., et al. Generation of lytic natural killer 1.1+, Ly-49- cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. J Exp Med 1997, 186:1609-1614.
25. Shimozato O., Ortaldo J.R., Komschlies K.L., Young H.A. Impaired NK cell development in an IFN-gamma transgenic mouse: aberrantly expressed IFN-gamma enhances hematopoietic stem cell apoptosis and affects NK cell differentiation. J Immunol 2002, 168:1746-1752.
26. Watt S.V., Andrews D.M., Takeda K., Smyth M.J., Hayakawa Y. IFN-gamma-dependent recruitment of mature CD27 (high) NK cells to lymph nodes primed by dendritic cells. J Immunol 2008, 181:5323-5330.
27. Hodge D.L., Schill W.B., Wang J.M., Blanca I., Reynolds D.A., Ortaldo J.R., et al. IL-2 and IL-12 alter NK cell responsiveness to IFN-gamma-inducible protein 10 by down-regulating CXCR3 expression. J Immunol 2002, 168:6090-6098.
28. Huntington N.D., Vosshenrich C.A., Di Santo J.P. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat Rev Immunol 2007, 7:703-714.
29. Gao B., Jeong W.I., Tian Z. Liver: an organ with predominant innate immunity. Hepatology 2008, 47:729-736.
30. Crispe I.N. The liver as a lymphoid organ. Annu Rev Immunol 2009, 27:147-163.
31. Ochi M., Ohdan H., Mitsuta H., Onoe T., Tokita D., Hara H., et al. Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice. Hepatology 2004, 39:1321-1331.
32. Andrews D.M., Smyth M.J. A potential role for RAG-1 in NK cell development revealed by analysis of NK cells during ontogeny. Immunol Cell Biol 2010, 88:107-116.
33. Burt B.M., Plitas G., Stableford J.A., Nguyen H.M., Bamboat Z.M., Pillarisetty V.G., et al. CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis. J Leukoc Biol 2008, 84:1039-1046.
34. Lassen M.G., Lukens J.R., Dolina J.S., Brown M.G., Hahn Y.S. Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state. J Immunol 2010, 184:2693-2701.
35. Chambers B.J., Ljunggren H.G. Unique features of NK cell development during ontogeny revealed in studies of RAG-1-deficient mice. Immunol Cell Biol 2010, 88:105-106.
36. Hayakawa Y., Smyth M.J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006, 176:1517-1524.
37. Chiossone L., Chaix J., Fuseri N., Roth C., Vivier E., Walzer T. Maturation of mouse NK cells is a 4-stage developmental program. Blood 2009, 113:5488-5496.
38. Loza M.J., Perussia B. Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation?. Nat Immunol 2001, 2:917-924.